Maintenance of serum antibody levels

Annual Review of Immunology

Volumn 23, Issue , 2005, Pages 367-386

  Manz, Rudolf A ^a   Hauser, Anja E ^a   Hiepe, Falk ^a,b   Radbruch, Andreas ^a,b  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Autoantibodies; Humoral immunity; Immunological memory; Plasma blasts; Plasma cells

Indexed keywords

ANTIBODY; ANTIGEN; AUTOANTIBODY; CD20 ANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SCREENING; B LYMPHOCYTE; BLAST CELL; CELL SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOPATHOLOGY; IMMUNOREGULATION; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REVIEW; VERTEBRATE;

ANIMALS; ANTIBODIES; ANTIBODY-PRODUCING CELLS; FEMALE; FETAL BLOOD; HUMANS; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; IMMUNOGLOBULIN ISOTYPES; IMMUNOLOGIC MEMORY; INFANT, NEWBORN; PLASMA CELLS; PREGNANCY;

EID: 14944361903     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.23.021704.115723     Document Type: Review

References (134)

1. Behring E, Kitasato S. 1890. Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren. Dtsch. Med. Wochenschr. 16(49): 1113-14
2. Rajewsky K. 1996. Clonal selection and learning in the antibody system. Nature 381:751-58
3. Boyden SV. 1966. Natural antibodies and the immune response. Adv. Immunol. 5:1-28
4. Michael JG. 1969. Natural antibodies. Curr. Top. Microbiol. Immunol. 48:43-62
5. Martin F, Chan AC. 2004. Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity 20:517-27
6. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, et al. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286:2156-59
7. Ahmed R, Gray D. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54-60
8. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, et al. 2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9:1131-37
9. Slifka MK, Matloubian M, Ahmed R. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69:1895-902
10. Simister NE, Story CM. 1997. Human placental Fc receptors and the transmission of antibodies from mother to fetus. J. Reprod. Immunol. 37:1-23
11. Nossal GJ. 2002. One cell, one anti-body: prelude and aftermath. Immunol. Rev. 185:15-23
12. McHeyzer-Williams M, McHeyzer-Williams L. 2004. Antigen-specific memory B cell development. Annu. Rev. Immunol. 23:487-513
13. Helmreich E, Kern M, Eisen HN. 1961. The secretion of antibody by isolated lymph node cells. J. Biol. Chem. 236:464-73
14. Hibi T, Dosch HM. 1986. Limiting dilution analysis of the B cell compartment in human bone marrow. Eur. J. Immunol. 16:139-45
15. Arce S, Luger E, Muehlinghaus G, Cassese G, Hauser A, et al. 2004. CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations. J. Leukoc. Biol. 75:1022-28
16. Brieva JA, Roldan E, De la Sen ML, Rodriguez C. 1991. Human in vivo-induced spontaneous IgG-secreting cells from tonsil, blood and bone marrow exhibit different phenotype and functional level of maturation. Immunology 72:580-83
17. Haaijman JJ, Schuit HR, Hijmans W. 1977. Immunoglobulin-containing cells in different lymphoid organs of the CBA mouse during its life-span. Immunology 32:427-34
18. Vieira P, Rajewsky K. 1988. The half-lives of serum immunoglobulins in adult mice. Eur. J. Immunol. 18:313-36
19. Talbot PJ, Buchmeier MJ. 1987. Catabolism of homologous murine monoclonal hybridoma IgG antibodies in mice. Immunology 60:485-89
20. Bienvenu J, Whicher J, Chir B, Aguzzi F. 1996. Immunoglobulins. In Serum Proteins in Clinical Medicine, ed. RF Ritchie, O Navolotskaia, pp. 1-16. Scarborough, ME: Found. Blood Res.
21. Radl J, Sepers JM, Skvaril F, Morell A, Hijmans W. 1975. Immunoglobulin patterns in humans over 95 years of age. Clin. Exp. Immunol. 22:84-90
22. Ghetie V, Ward ES. 2000. Multiple roles for the major histocompatibility complex class I- related receptor FcRn. Annu. Rev. Immunol. 18:739-66
23. Rifai A, Fadden K, Morrison SL, Chintalacharuvu KR. 2000. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J. Exp. Med. 191:2171-82
24. Mestecky J, McGhee JR. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153-245
25. Kerr MA. 1990. The structure and function of human IgA. Biochem. J. 271:285-96
26. Metzger H. 1970. Structure and function of gamma M macroglobulins. Adv. Immunol. 12:57-116
27. Parkhouse RM, Askonas BA, Dourmashkin RR. 1970. Electron microscopic studies of mouse immunoglobulin M; structure and reconstitution following reduction. Immunology 18:575-84
28. Spiegelberg HL. 1977. The structure and biology of human IgD. Immunol. Rev. 37:3-24
29. Waldmann TA. 1969. Disorders of immunoglobulin metabolism. N. Engl. J. Med. 281:1170-77
30. Herzenberg LA, Stall AM, Lalor PA, Sidman C, Moore WA, Parks DR. 1986. The Ly-1 B cell lineage. Immunol. Rev. 93:81-102
31. Casali P, Schettino EW. 1996. Structure and function of natural antibodies. Curr. Top. Microbiol. Immunol. 210:167-79
32. Sheldrake RF, Husband AJ, Watson DL, Cripps AW. 1984. Selective transport of serum-derived IgA into mucosal secretions. J. Immunol. 132:363-68
33. Lilius EM, Marnila P. 2001. The role of colostral antibodies in prevention of microbial infections. Curr. Opin. Infect. Dis. 14:295-300
34. Telemo E, Westrom BR, Ekstrom G, Karlsson BW. 1987. Intestinal macro-molecular transmission in the young rat: influence of protease inhibitors during development. Biol. Neonate 52:141-48
35. Simister NE, Mostov KE. 1989. An Fc receptor structurally related to MHC class I antigens. Nature 337:184-87
36. Story CM, Mikulska JE, Simister NE. 1994. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J. Exp. Med. 180:2377-81
37. Simister NE, Story CM, Chen HL, Hunt JS. 1996. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur. J. Immunol. 26:1527-31
38. Leach JL, Sedmak DD, Osborne JM, Rahill B, Lairmore MD, Anderson CL. 1996. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J. Immunol. 157:3317-22
39. Kristoffersen EK, Matre R. 1996. Colocalization of the neonatal Fc gamma receptor and IgG in human placental term syncytiotrophoblasts. Eur. J. Immunol. 26:1668-71
40. Tizard I. 2001. The protective properties of milk and colostrum in non-human species. Adv. Nutr. Res. 10:139-66
41. Roberts DM, Guenthert M, Rodewald R. 1990. Isolation and characterization of the Fc receptor from the fetal yolk sac of the rat. J. Cell Biol. 111:1867-76
42. Ghetie V, Hubbard JG, Kim JK, Tsen MF, Lee Y, Ward ES. 1996. Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur. J. Immunol. 26:690-96
43. Lazarus NH, Kunkel EJ, Johnston B, Wilson E, Youngman KR, Butcher EC. 2003. A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J. Immunol. 170:3799-805
44. Kato H, Kato R, Fujihashi K, McGhee JR. 2001. Role of mucosal antibodies in viral infections. Curr. Top. Microbiol. Immunol. 260:201-28
45. Youngman KR, Franco MA, Kuklin NA, Rott LS, Butcher EC, Greenberg HB. 2002. Correlation of tissue distribution, developmental phenotype, and intestinal homing receptor expression of antigen-specific B cells during the murine anti-rotavirus immune response. J. Immunol. 168:2173-81
46. Fagarasan S, Kinoshita K, Muramatsu M, Ikuta K, Honjo T. 2001. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413:639-43
47. Bowman EP, Kuklin NA, Youngman KR, Lazarus NH, Kunkel EJ, et al. 2002. The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J. Exp. Med. 195:269-75
48. Lamm ME, Phillips-Quagliata JM. 2002. Origin and homing of intestinal IgA antibody-secreting cells. J. Exp. Med. 195:F5-8
49. Pan JL, Kunkel EJ, Gosslar U, Lazarus N, Langdon P, et al. 2000. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J. Immunol. 165:2943-49
50. Kunkel EJ, Kim CH, Lazarus NH, Vierra MA, Soler D, et al. 2003. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J. Clin. Invest. 111:1001-10
51. Hieshima K, Ohtani H, Shibano M, Izawa D, Nakayama T, et al. 2003. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J. Immunol. 170:1452-61
52. Kunkel EJ, Campbell JJ, Haraldsen G, Pan JL, Boisvert J, et al. 2000. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J. Exp. Med. 192:761-67
53. Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, et al. 2000. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J. Immunol. 165:5069-76
54. Pabst O, Ohl L, Wendland M, Wurbel MA, Kremmer E, et al. 2004. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J. Exp. Med. 199:411-16
55. Quiding-Jarbrink M, Nordstrom I, Granstrom G, Kilander A, Jertborn M, et al. 1997. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J. Clin. Invest. 99:1281-86
56. Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC. 1991. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur. J. Immunol. 21:2951-62
57. Smith KG, Hewitson TD, Nossal GJ, Tarlinton DM. 1996. The phenotype and fate of the antibody-forming cells of the splenic foci. Eur. J. Immunol. 26:444-48
58. de Vinuesa CG, Gulbranson-Judge A, Khan M, O'Leary P, Cascalho M, et al. 1999. Dendritic cells associated with plasmablast survival. Eur. J. Immunol. 29:3712-21
59. McMillan R, Longmire RL, Yelenosky R, Lang JE, Heath V. Craddock CG. 1972. Immunoglobulin synthesis by human lymphoid tissues: normal bone marrow as a major site of IgG production. J. Immunol. 109:1386-94
60. Benner R, van Oudenaren A. 1975. Antibody formation in mouse bone marrow. IV. The influence of splenectomy on the bone marrow plaque-forming cell response to sheep red blood cells. Cell Immunol. 19:167-82
61. Hauser AE, Debes GF, Arce S, Cassese G, Hamann A, et al. 2002. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J. Immunol. 169:1277-82
62. Dilosa RM, Maeda K, Masuda A, Szakal AK, Tew JG. 1991. Germinal center B cells and antibody production in the bone marrow. J. Immunol. 146:4071-77
63. Benner R, Hijmans W, Haaijman JJ. 1981. The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin. Exp. Immunol. 46:1-8
64. Tew JG, DiLosa RM, Burton GF, Kosco MH, Kupp LI, et al. 1992. Germinal centers and antibody production in bone marrow, Immunol. Rev. 126:99-112
65. Takahashi Y, Dutta PR, Cerasoli DM, Kelsoe G. 1998. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection. J. Exp. Med. 187:885-95
66. Smith KG, Light A, Nossal GJ, Tarlinton DM. 1997. The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response. EMBO J. 16:2996-3006
67. Hay JB, Murphy MJ, Morris B, Bessis MC. 1972. Quantitative studies on the proliferation and differentiation of antibody-forming cells in lymph. Am. J. Pathol. 66:1-24
68. Cupps TR, Goldsmith PK, Volkman DJ, Gerin JL, Purcell RH, Fauci AS. 1984. Activation of human peripheral blood B cells following immunization with hepatitis B surface antigen vaccine. Cell Immunol. 86:145-54
69. Koch G, Osmond DG, Julius MH, Benner R. 1981. The mechanism of thymus-dependent antibody formation in bone marrow. J. Immunol. 126:1447-51
70. Ridley RC, Xiao H, Hata H, Woodliff J, Epstein J, Sanderson RD. 1993. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 81:767-74
71. Medina F, Segundo C, Campos-Caro A, Gonzalez-Garcia I, Brieva JA. 2002. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 99:2154-61
72. Wehrli N, Legier DF, Finke D, Toellner KM, Loetscher P, et al. 2001. Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur. J. Immunol. 31:609-16
73. Reif K, Ekland EH, Ohl L, Nakano H, Lipp M, et al. 2002. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416:94-99
74. Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, et al. 2001. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194:45-56
75. Cassese G, Arce S, Hauser AE, Lehnert K, Moewes B, et al. 2003. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171:1684-90
76. Manz RA, Arce S, Cassese G, Hauser AE, Hiepe F, Radbruch A. 2002. Humoral immunity and long-lived plasma cells. Curr. Opin. Immunol. 14:517-21
77. Janatpour MJ, Hudak S, Sathe M, Sedgwick JD, McEvoy LM. 2001. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J. Exp. Med. 194:1375-84
78. Cassese G, Lindenau S, de Boer B, Arce S, Hauser A, et al. 2001. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur. J. Immunol. 31:2726-32
79. Mallison SM 3rd, Szakal AK, Ranney RR, Tew JG. 1988. Antibody synthesis specific for nonoral antigens in inflamed gingiva. Infect. Immun. 56:823-30
80. Hook WA, Toussaint AI, Simonton LA, Muschel LH. 1966. Appearance of natural antibodies in young rabbits. Nature 210:543-44
81. Cohen IR, Norins LC. 1966. Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M. Science 152:1257-59
82. Kantor AB. 1991. The development and repertoire of B-1 cells (CD5 B cells). Immunol. Today 12:389-91
83. - B lymphocyte subset producing natural antibodies. J. Immunol. 148:2690-702
84. Jiang HQ, Thurnheer MC, Zuercher AW, Boiko NV, Bos NA, Cebra JJ. 2004. Interactions of commensal gut microbes with subsets of B- and T-cells in the murine host. Vaccine 22:805-11
85. Kantor AB, Herzenberg LA. 1993. Origin of murine B cell lineages. Annu. Rev. Immunol. 11:501-38
86. + B cells. Immunol. Rev. 137:91-118
87. Tlaskalova-Hogenova H, Mandel L, Stepankova R, Bartova J, Barot R, et al. 1992. Autoimmunity: from physiology to pathology. Natural antibodies, mucosal immunity and development of B cell repertoire. Folia Biol. 38:202-15
88. Coutinho A, Kazatchkine MD, Avrameas S. 1995. Natural autoantibodies. Curr. Opin. Immmol. 7:812-18
89. Bos NA, Kimura H, Meeuwsen CG, De Visser H, Hazenberg MP, et al. 1989. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur. J. Immunol. 19:2335-39
90. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. 2000. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288:2222-26
91. Ferry H, Jones M, Vaux DJ, Roberts IS, Cornall R. 2003. The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells. J. Exp.Med. 198:1415-25
92. Mouthon L, Nobrega A, Nicolas N, Kaveri SV, Barreau C, et al. 1995. Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM anti-body repertoires and prevail in autoreactive repertoires of healthy adults. Proc. Natl. Acad. Sci. USA 92:3839-43
93. Slifka MK, Ahmed R. 1996. Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Trends Microbiol. 4:394-400
94. Manz RA, Lohning M, Cassese G, Thiel A, Radbruch A. 1998. Survival of long-lived plasma cells is independent of antigen. Int. Immunol. 10:1703-11
95. Tew JG, Phipps RP, Mandel TE. 1980. The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells. Immunol. Rev. 53:175-201
96. Bachmann MF, Odermatt B, Hengartner H, Zinkernagel RM. 1996. Induction of long-lived germinal centers associated with persisting antigen after viral infection. J. Exp. Med. 183:2259-69
97. Slifka MK, Antia R, Whitmire JK, Ahmed R. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8:363-72
98. Manz RA, Thiel A, Radbruch A. 1997. Lifetime of plasma cells in the bone marrow. Nature 388:133-34
99. Schittek B, Rajewsky K. 1990. Maintenance of B-cell memory by long-lived cells generated from proliferating precursors. Nature 346:749-51
100. Wols HAM, Underhill GH, Kansas GS, Witte PL. 2002. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J. Immunol. 169:4213-21
101. Tokoyoda K, Egawa T, Sugiyama T, Choi BI, Nagasawa T. 2004. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20:707-18
102. Manz RA, Radbruch A. 2002. Plasma cells for a lifetime? Eur. J. Immunol. 32:923-27
103. Freitas AA, Rocha B. 2000. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18:83-111
104. Zhang JW, Niu C, Ye L, Huang HY, He X, et al. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425:836-41
105. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841-46
106. Roldan E, Brieva JA. 1991. Terminal differentiation of human bone marrow cells capable of spontaneous and high-rate immunoglobulin secretion: role of bone marrow stromal cells and interleukin 6. Eur. J. Immunol. 21:2671-77
107. + tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J. Exp. Med. 183:227-36
108. Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A. 1995. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 85:487-94
109. Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, et al. 2001. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B cell maturation in mice lacking BLyS. Immunity 15:289-302
110. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, et al. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111-14
111. O'Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, et al. 2004. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199:91-98
112. Bernasconi NL, Traggiai E, Lanzavecchia A. 2002. Maintenance of serological memory by polyclonal activation of human emory B cells. Science 298:2199-202
113. Martin F, Kearney JF. 2000. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory." Immunol. Rev. 175:70-79
114. Davidson A, Diamond B. 2001. Autoimmune diseases. N. Engl. J. Med. 345:340-50
115. Cheema GS, Roschke V, Hubert DM, Stohl W. 2001. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44:1313-19
116. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, et al. 2002. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J. Clin. Invest. 109:59-68
117. Zhang J, Roschke V, Baker KP, Wang Z, Alarcon GS, et al. 2001. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166:6-10
118. Hahn BH. 1998. Antibodies to DNA. N. Engl. J. Med. 338:1359-68
119. Riemekasten G, Marell J, Trebeljahr G, Klein R, Hausdorf G, et al. 1998. A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J. Clin. Invest. 102:754-63
120. Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F. 2000. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum. 43:2307-15
121. Rosen O, Thiel A, Massenkeil G, Hiepe F, Haupl T, et al. 2000. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res. 2:327-36
122. Traynor AE, Schroeder J, Rosa RM. Cheng D, Stefka J, et al. 2000. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 356:701-7
123. Izumi N, Fuse I, Furukawa T, Uesugi Y, Tsuchiyama J, et al. 2003. Long-term production of pre-existing alloantibodies to E and c after allogenic BMT in a patient with aplastic anemia resulting in delayed hemolytic anemia. Transfusion 43:241-45
124. Wahren M, Tengner P, Gunnarsson I, Lundberg I, Hedfors E, et al. 1998. Ro/SS-A and La/SS-B antibody level variation in patients with Sjögren's syndrome and systemic lupus erythematosus. J. Autoimmun. 11:29-38
125. Westman KW, Bygren PG, Ericsson UB, Hoier-Madsen M, Wieslander J, Erfurth EM. 1998. Persistent high prevalence of thyroid antibodies after immunosuppressive therapy in subjects with glomerulonephritis. A prospective three-year follow-up study. Am. J. Nephrol. 18:274-79
126. De Block CE, De Leeuw IH, Rooman RP, Winnock F, Du Caju MV, Van Gaal LF. 2000. Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA 1*0501-DQB1*0301 haplotype in type 1 diabetes mellitus. Diabet. Med. 17:618-22
127. Decochez K, Tits J, Coolens JL, Van Gaal L, Krzentowski G, et al. 2000. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. Diabetes Care 23:838-44
128. Hoyer BF, Moser K, Hauser AE, Peddinghaus A, Voigt C, et al. 2004. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J. Exp. Med. 199:1577-84
129. Leandro MJ, Edwards JC, Cambridge G, Ehrenstein MR, Isenberg DA. 2002. An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum. 46:2673-77
130. Silverman GJ, Weisman S. 2003. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum. 48:1484-92
131. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, et al. 2004. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350:2572-81
132. Cambridge G, Leandro MJ, Edwards JC, Ehrenstein MR, Salden M, et al. 2003. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum. 48:2146-54
133. high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 48:1332-42
134. Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, et al. 2000. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol. 165:5970-79